Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 3,049-3,060 of 10,592

Other study type icon

WithdrawnNCT03547882

Addiction Treatment in Primary Care Expansion

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionOther

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Addiction

Drug study icon

CompletedNCT00218426

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 50 Years

Countries: United States, Russia
Sponsor: University of Pennsylvania
Condition: Addiction

Behavioral study icon

CompletedNCT04991974

Addiction Treatment Linkage at Strategic Touchpoints Using Buprenorphine

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Friends Research Institute, Inc.
Condition: Addiction

Other study type icon

CompletedNCT04155385

Addiction Treatment Outcome Monitoring Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionOtherOver 18 Years

Countries: United States
Sponsor: University of Washington
Condition: Addiction

Behavioral study icon

Active Not RecruitingNCT04567394

Addiction Treatment Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 25 Years

Countries: United States
Sponsor: The University of Tennessee, Knoxville
Condition: Addiction

Device study icon

WithdrawnNCT05910749

Addiction, Brain and Behavioral Regulation

This summary needs review. Please check the official study record and contact the research team for details.

Broader result

AddictionDeviceFrom 21 Years to 51 Years

Countries: United States
Sponsor: University of Puerto Rico
Condition: Addiction

Behavioral study icon

CompletedNCT01664741

Addiction, Withdrawal and Replacement Therapy Assessed by PET Imaging

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 21 Years to 60 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Addiction

Other study type icon

Enrolling By InvitationNCT04946851

Addictions Neuroclinical Assessment (ANA)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionOtherFrom 18 Years to 99 Years

Countries: United States
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition: Addiction

Other study type icon

CompletedNCT03496077

Addictive Potential of LCCs in Dual Users

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionOtherFrom 18 Years to 34 Years

Countries: United States
Sponsor: UConn Health
Condition: Addiction

Behavioral study icon

CompletedNCT00601354

Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersBehavioralOver 18 Years

Countries: United States
Sponsor: Stanford University
Condition: Eating disorders

Drug study icon

CompletedNCT04889664

Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Icahn School of Medicine at Mount Sinai
Condition: PTSD

Drug study icon

CompletedNCT00149734

Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of Colorado, Denver
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.